News
The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...
An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to ...
Startup Clairity scored a greenlight from the FDA for the agency's first artificial intelligence tool designed to predict ...
Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...
California and three other states have called on the FDA to ease new restrictions on the abortion pill mifepristone, which ...
RadNet, Inc. (NASDAQ:RDNT) has moved to strengthen its prospects on the use of artificial intelligence to enhance ultrasound ...
In this episode of Denatured, presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses how AI transformation can ...
The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...
The analyst supported the positive rating with Ojemda’s potential, which is a prescription medicine that treats certain brain ...
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...
A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, “Clarity,” is responsible for the first FDA-approved AI platform that helps predict a woman’s ...
A new FDA artificial intelligence tool designed to streamline medical device reviews is faltering in its early rollout stages, raising concerns for agency staff and ethics experts about its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results